A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2027, filed Sep 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MSB SEC filings page.
Mesabi Trust (MSB) reported $11.9M in revenue over the twelve months to Jul 31, 2026, down 87.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Mesabi Trust’s reported financial scale is highly cyclical, with FY2026 assets and earnings far below FY2025 despite lower liabilities.
The FY2025-to-FY2026 contraction reduced net income by85.1% and total assets by76.1% , linking earnings volatility with the reported asset base. Liabilities fell95.0% over the same interval, leaving a smaller balance sheet with a lower liability burden; the trust’s scale is variable rather than steadily expanding.
In FY2026, net income was
FY2026 operating cash flow of
Financial Health Signals
We do not publish a peer-relative financial health score for Mesabi Trust, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Mesabi Trust passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Mesabi Trust generates $1.04 in operating cash flow ($14.4M OCF vs $13.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Mesabi Trust generated $2.5M in revenue in Q2 2027. This represents a decrease of 55.8% from the same quarter a year earlier. Against the prior quarter it is up 10.4%.
Mesabi Trust reported a net loss of $95K in Q2 2027. This represents a decrease of 102.0% from the same quarter a year earlier. Against the prior quarter it is down 108.7%.
Not reported for Q2 2027.
Not reported for Q2 2027.
Cash & Balance Sheet
Mesabi Trust held $17.4M in cash as of Q2 2027; no long-term debt figure is on record for that period.
Not reported for Q2 2027.
Not reported for Q2 2027.
Margins & Returns
Mesabi Trust's gross margin was -3.8% in Q2 2027, indicating the percentage of revenue retained after direct costs. This is down 88.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 52.3 percentage points.
Mesabi Trust's net profit margin was -3.8% in Q2 2027, showing the share of revenue converted to profit. This is down 88.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 52.3 percentage points.
Mesabi Trust's quarterly ROE was -0.5% in Q2 2027: one quarter's net income over shareholder equity, not annualized. This is down 21.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.5 percentage points.
Not reported for Q2 2027.
Capital Allocation
None of these metrics is reported for Q2 2027.
MSB Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5M-55.8% | $2.2M-52.6% | $3.6M-47.6% | $3.6M-95.5% | $5.6M-13.6% | $4.7M-24.3% | $6.9M+10.0% | $79.0M+1513.6% |
| Cost of Revenue | $2.6M+198.5% | $1.2M+5.0% | N/A | $823K+21.7% | $863K-21.0% | $1.1M-60.1% | $786K-48.8% | $676K-16.5% |
| Gross Profit | -$95K-102.0% | $1.1M-70.1% | N/A | $2.8M-96.5% | $4.7M-12.1% | $3.6M+4.2% | $6.1M+29.3% | $78.3M+1816.9% |
| Net Income | -$95K-102.0% | $1.1M-70.1% | $2.7M-55.1% | $2.8M-96.5% | $4.7M-12.1% | $3.6M+4.2% | $6.1M+29.3% | $78.3M+1816.9% |
| EPS (Basic) | -$0.01-102.0% | $0.08-70.1% | N/A | $0.21-96.5% | $0.36-12.1% | $0.28+4.3% | $0.46+29.2% | $5.97+1817.1% |
Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, EPS (Diluted), Diluted Shares (Avg).
MSB Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $19.8M-19.9% | $21.9M-20.1% | $24.4M-76.1% | $26.0M-74.2% | $24.8M-5.6% | $27.4M+9.1% | $101.7M+281.1% | $100.7M+287.0% |
| Current Assets | $19.8M-19.9% | $21.9M-20.1% | $24.4M-76.1% | $26.0M-74.2% | $24.8M-5.6% | $27.4M+9.1% | $101.7M+281.1% | $100.7M+287.0% |
| Cash & Equivalents | $17.4M-18.2% | $20.3M-16.3% | $23.2M-76.9% | $23.2M-75.8% | $21.2M-1.8% | $24.2M+12.0% | $100.2M+317.9% | $95.9M+318.6% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Accounts Receivable | $968K-33.0% | $632K-67.0% | $782K-32.6% | $1.5M-60.8% | $1.4M-44.1% | $1.9M+4.8% | $1.2M-40.8% | $3.9M+106.0% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $2.3M+12.9% | $3.6M-54.2% | $4.0M-95.0% | $4.9M-8.1% | $2.0M-51.7% | $7.8M+74.6% | $78.4M+1271.8% | $5.3M+9.6% |
| Total Equity | $17.6M-22.8% | $18.3M-6.5% | $20.4M-12.5% | $21.1M-77.9% | $22.8M+3.0% | $19.6M-5.0% | $23.3M+11.2% | $95.3M+350.9% |
Not reported in any period shown, so not listed: Inventory, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt, Retained Earnings.
MSB Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Share Buybacks.
MSB Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2710-Q | Q1'2710-Q | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -3.8%-88.4pp | 48.4%-28.3pp | N/A | 77.1%-22.1pp | 84.6%+1.4pp | 76.7%+21.0pp | 88.5%+13.2pp | 99.1%+15.7pp |
| Net Margin | -3.8%-88.4pp | 48.4%-28.3pp | 75.9%-12.6pp | 77.1%-22.1pp | 84.6%+1.4pp | 76.7%+21.0pp | 88.5%+13.2pp | 99.1%+15.7pp |
| Return on Equity | -0.5%-21.4pp | 5.9%-12.6pp | 13.4%-12.7pp | 13.1%-69.0pp | 20.8%-3.6pp | 18.5%+1.7pp | 26.0%+3.7pp | 82.2%+62.8pp |
| Return on Assets | -0.5%-19.6pp | 5.0%-8.3pp | 11.2%+5.2pp | 10.6%-67.2pp | 19.1%-1.4pp | 13.2%-0.6pp | 6.0%-11.6pp | 77.8%+62.1pp |
| Liabilities-to-Equity | 0.130.0x | 0.20-0.2x | 0.19-3.2x | 0.23+0.2x | 0.09-0.1x | 0.40+0.2x | 3.36+3.1x | 0.06-0.2x |
| Asset Turnover | 0.13-0.1x | 0.10-0.1x | 0.15+0.1x | 0.14-0.6x | 0.230.0x | 0.17-0.1x | 0.07-0.2x | 0.78+0.6x |
Not reported in any period shown, so not listed: Operating Margin, Current Ratio, Debt-to-Equity, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Mesabi Trust MSB | FY2026 | $17.5M | $13.9M | 79.1% | $209.4M | — |
| Friedman Industries Inc. FRD | FY2026 | $646.9M | $19.5M | 3.0% | $255.9M | 51/100 |
| ZK International Group Co., Ltd ZKIN | FY2025 | $71.2M | -$4.0M | -5.6% | $88.6M | 46/100 |
| Luda Technology Group Limited LUD | FY2025 | $33.5M | $557K | 1.7% | $85.1M | 38/100 |
| Hongli Group Inc. HLP | FY2025 | $19.6M | $1.9M | 9.9% | $272.8M | 46/100 |
| Algoma Steel Group Inc. ASTL | FY2025 | $1.5B | -$718.3M | -47.2% | $566.3M | 22/100 |
Where Mesabi Trust Ranks
Frequently Asked Questions
Mesabi Trust (MSB) reported $17.5M in total revenue for fiscal year 2026. This represents a -82.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Mesabi Trust (MSB) revenue declined by 82.2% year-over-year, from $98.6M to $17.5M in fiscal year 2026.
Yes, Mesabi Trust (MSB) reported a net income of $6.5M over the trailing 12 months to July 31, 2026. In fiscal year 2026 it reported a net income of $13.9M, with a net profit margin of 79.1%.
Mesabi Trust (MSB) had a gross margin of 79.1% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
Mesabi Trust (MSB) had a net profit margin of 79.1% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Mesabi Trust (MSB) has a return on equity of 68.0% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
Mesabi Trust (MSB) generated $14.4M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
Mesabi Trust (MSB) had $24.4M in total assets as of fiscal year 2026, including both current and long-term assets.
Mesabi Trust (MSB) had a liabilities-to-equity ratio of 0.19 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2026, because the filing data we hold for that year carries no long-term debt figure.
Mesabi Trust (MSB) had a return on assets of 56.9% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
Mesabi Trust (MSB) trades at 32.3x earnings, its market capitalization divided by $6.5M net income, trailing 12 months to July 31, 2026. The market capitalization is $209.4M as of Nov 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Mesabi Trust (MSB) trades at 17.6x sales, its market capitalization divided by $11.9M revenue, trailing 12 months to July 31, 2026. The market capitalization is $209.4M as of Nov 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Mesabi Trust (MSB) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Mesabi Trust (MSB) has an earnings quality ratio of 1.04x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.